Millennium: The Takeda Oncology Company – mifamurtide

Rating: 0 - 0 votes

Company Logo

Company Name

Company Contact

Website Analysis

• Home Page Analysis
• Web Presence
• Home Page Speed

Domain Whois

WHOIS information for idm-biotech.com

Powered by who.is

Page Type

This page is about a company.

Description

pulled from site's meta description

Millennium develops and markets VELCADE (R) (bortezomib) for Injection, a first-in-class cancer therapy for the treatment of patients with multiple myeloma and relapsed mantle cell lymphoma.

---

This is an automatically generated AboutUs page for idm-biotech.com. Click the "Edit" button at the top of the page to make changes. Please read our Getting Started page if you need any help.

×

Edit Page Image

×

Select image...

• jpeg, png, or gif
• one megabyte or smaller
• will be resized to 270 pixels wide

Close Save changes

×

Edit Name

×

Name

Close Save changes

×

Edit Contact Information

×

Address

City

State

Country

Postal Code

Phone

Fax

Email

Close Save changes

×

Edit Page Type

×

Page Type
Business / Organization Person Place Thing Other

Close Save changes

×

Map

×

×

Edit Page Rating

×

Your Rating

Close Save changes